Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 947,501
  • Shares Outstanding, K 62,790
  • Annual Sales, $ 30,340 K
  • Annual Income, $ -178,410 K
  • 60-Month Beta 2.43
  • Price/Sales 31.96
  • Price/Cash Flow N/A
  • Price/Book 15.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.67
  • Number of Estimates 6
  • High Estimate -0.61
  • Low Estimate -0.74
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +30.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.06 +50.00%
on 10/14/19
15.74 -4.13%
on 11/12/19
+4.89 (+47.94%)
since 10/11/19
3-Month
8.02 +88.15%
on 09/04/19
15.74 -4.13%
on 11/12/19
+6.24 (+70.51%)
since 08/13/19
52-Week
3.92 +284.95%
on 03/01/19
15.74 -4.13%
on 11/12/19
+4.11 (+37.43%)
since 11/13/18

Most Recent Stories

More News
Karyopharm Thera Set to Possibly Pullback After Yesterday's Rally of 48.01%

Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $14.60 to a high of $15.07. Yesterday, the shares gained 48.0%, which took the trading range above the 3-day high...

KPTI : 15.09 (-2.27%)
Watch for Karyopharm Thera to Potentially Pullback After Gaining 42.78% Yesterday

Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $14.15 to a high of $14.69. Yesterday, the shares gained 42.8%, which took the trading range above the 3-day high...

KPTI : 15.09 (-2.27%)
Karyopharm Announces XPOVIO(R) (Selinexor) Clinical Data to be Presented at the American Society of Hematology 2019 Annual Meeting

-- Updated Results from the Pomalyst(R) and Kyprolis(R) Arms of the Phase 1b/2 STOMP Study Evaluating Selinexor in Combination with Other Approved Myeloma Therapies in Relapsed or Refractory Multiple Myeloma...

KPTI : 15.09 (-2.27%)
Karyopharm (KPTI) Catches Eye: Stock Jumps 6.4%

Karyopharm (KPTI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

FGEN : 34.58 (-2.76%)
KPTI : 15.09 (-2.27%)
Karyopharm Thera has the Best Relative Performance in the Biotechnology Industry (KPTI , IRWD , SRPT , TGTX , DVAX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

IRWD : 11.38 (+0.22%)
KPTI : 15.09 (-2.27%)
SRPT : 101.00 (+1.05%)
Karyopharm Therapeutics (KPTI) Reports Q3 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of 20.24% and 718.23%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

KPTI : 15.09 (-2.27%)
Karyopharm Therapeutics: 3Q Earnings Snapshot

NEWTON, Mass. (AP) _ Karyopharm Therapeutics Inc. (KPTI) on Monday reported a loss of $41.4 million in its third quarter.

KPTI : 15.09 (-2.27%)
Karyopharm Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress

â?' XPOVIO Phase 2b STORM Study Results Published in The New England Journal of Medicine â?'

KPTI : 15.09 (-2.27%)
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an oncology-focused pharmaceutical company, today announced that the Compensation Committee of Karyopharm's Board of Directors granted stock options to purchase...

KPTI : 15.09 (-2.27%)
Karyopharm to Report Third Quarter 2019 Financial Results on November 4, 2019

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that it will report third quarter 2019 financial results on Monday, November 4, 2019. Karyopharm's...

KPTI : 15.09 (-2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade KPTI with:

Business Summary

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

See More

Key Turning Points

2nd Resistance Point 16.10
1st Resistance Point 15.59
Last Price 15.09
1st Support Level 14.70
2nd Support Level 14.32

See More

52-Week High 15.74
Last Price 15.09
Fibonacci 61.8% 11.22
Fibonacci 50% 9.83
Fibonacci 38.2% 8.44
52-Week Low 3.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar